GeneChem is a manager of focused biotechnology venture capital funds. Actively supports companies that discover & develop novel therapeutics from genomic targets. It has over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in investing in companies involved in drug discovery and development. Together, they have invested in over 60 companies in the US, Canada and Europe.